S&P Global Ratings is considering whether to reclassify Centene Corp.'s credit ratings to junk, which would strongly impact its borrowing power. Centene, the top seller of ACA health plans, is ...

S&P Global Ratings said it's considering cutting Centene Corp.'s credit ratings to junk, citing the health insurer's suspending its 2025 profit outlook. Centene said last week that it was withdrawing ...

With a market cap of $16.6 billion, Centene Corporation (CNC) is a multinational healthcare enterprise that delivers services ...

Shares of Centene ($CNC) plunged 40% on Wednesday after the healthcare insurer unexpectedly pulled its 2025 guidance. The ...

Investing.com - JPMorgan downgraded Centene (NYSE:CNC), a $28.19 billion healthcare provider trading at 8.46x earnings, from Overweight to Neutral on Tuesday, slashing its price target to $48.00 ...

(Reuters) -Centene Corp on Tuesday maintained its long-term profit growth targets allaying investor concerns over a blow to its business from competition in the fast-growing Medicare Advantage ...

Centene's Medicare Advantage star ratings scores for 2023 will be disappointing, executives warned during an earnings call on July 26, 2022. Samantha Liss/Healthcare Dive ...

While quality concerns remain even after the resolution of litigation and revisions to the CMS Star score calculation demanded by health plans nationwide, Centene's true strength and the bulk of ...

On Monday, Barclays analysts downgraded Centene stock (NYSE: NYSE:CNC) from Overweight to Equalweight, highlighting growing concerns in the Part D and Affordable Care Act (ACA) segments. The ...

Oct 22 (Reuters) - Health insurance company Centene (CNC.N), opens new tab accused U.S. regulators of unfairly downgrading the star ratings for its government-funded Medicare plans in a lawsuit on ...

In response, Centene is refiling its 2026 marketplace rates to address these challenges. UBS downgraded Centene’s stock from Buy to Neutral, citing the company’s withdrawal of guidance and concerns ...

On Monday, Barclays (LON: BARC) analysts downgraded Centene stock (NYSE: NYSE: CNC) from Overweight to Equalweight, highlighting growing concerns in the Part D and Affordable Care Act (ACA) ...